Latest Breaking News On - Signatures characterizing - Page 1 : comparemela.com

/PRNewswire/ Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced.

Harvard universityUnited statesPetera merkelDominic borieGeorg schettYale universityHospital harvard medical schoolCollaborative research centreHead of the department internal medicineFriedrich alexander universityUniversity of innsbruckGerman research foundationHospital of the university pennsylvaniaScleroderma clinical trials consortiumUniversity of pennsylvaniaNational academy of sciences germany